DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 8Dr. Reddy's Laboratories
02 2Actavis Inc
03 4Alembic Pharmaceuticals Limited
04 4ENDO OPERATIONS
05 4Gebro Pharma
06 4Ideogen AG
07 1ORIFARM GROUP AS
08 4OrPha Swiss
09 4Sandoz B2B
10 4Teva Pharmaceutical Industries
11 33United Therapeutics
01 5INFUSIONSVÄTSKA, LÖSNING
02 28INJECTABLE;IV (INFUSION), SUBCUTANEOUS
03 2Inf Soluble
04 10Inf Solution
05 4Infusion fluid, resolution
06 4Injection
07 4POWDER;INHALATION
08 4SOLUTION
09 1SOLUTION;INHALATION
10 4SOLUTION;INTRAVENOUS, SUBCUTANEOUS
11 2TABLET, EXTENDED RELEASE;ORAL
12 1Treprostinil 100Mg 20Ml 1 Units Parenteral Use
13 1Treprostinil 200Mg 20Ml 1 Units Parenteral Use
14 1Treprostinil 20Mg 20Ml 1 Units Parenteral Use
15 1Treprostinil 50Mg 20Ml 1 Units Parenteral Use
01 4DISCN
02 4Lead Market Dossiers- Filed
03 4Prescription
04 33RX
05 27Blank
01 16REMODULIN
02 17Remodulin
03 22TREPROSTINIL
04 1TYVASO
05 4TYVASO DPI
06 4Treprostinil Ideogen
07 4Treprostinil OrPha
08 4Blank
01 4Canada
02 4India
03 4Italy
04 4Norway
05 5Sweden
06 12Switzerland
07 39USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 1MG/ML
Packaging :
Approval Date : 2020-05-22
Application Number : 210214
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 2.5MG/ML
Packaging :
Approval Date : 2020-05-22
Application Number : 210214
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 5MG/ML
Packaging :
Approval Date : 2020-05-22
Application Number : 210214
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 10MG/ML
Packaging :
Approval Date : 2020-05-22
Application Number : 210214
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 1MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 2.5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 5MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 10MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info :
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 0.125MG
Packaging :
Approval Date :
Application Number : 208906
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 1MG/ML
Packaging :
Approval Date : 2017-11-30
Application Number : 203649
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 2.5MG/ML
Packaging :
Approval Date : 2017-11-30
Application Number : 203649
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 5MG/ML
Packaging :
Approval Date : 2017-11-30
Application Number : 203649
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 10MG/ML
Packaging :
Approval Date : 2017-11-30
Application Number : 203649
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 1MG/ML
Packaging :
Approval Date : 2019-09-26
Application Number : 206648
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 2.5MG/ML
Packaging :
Approval Date : 2019-09-26
Application Number : 206648
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 5MG/ML
Packaging :
Approval Date : 2019-09-26
Application Number : 206648
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TREPROSTINIL
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 10MG/ML
Packaging :
Approval Date : 2019-09-26
Application Number : 206648
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 1MG/ML
Packaging :
Approval Date : 2002-05-21
Application Number : 21272
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 2.5MG/ML
Packaging :
Approval Date : 2002-05-21
Application Number : 21272
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 5MG/ML
Packaging :
Approval Date : 2002-05-21
Application Number : 21272
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 10MG/ML
Packaging :
Approval Date : 2002-05-21
Application Number : 21272
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 20MG/ML
Packaging :
Approval Date : 2021-07-30
Application Number : 21272
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 0.1MG/ML
Packaging :
Approval Date : 2023-09-28
Application Number : 21272
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 0.2MG/ML
Packaging :
Approval Date : 2023-09-28
Application Number : 21272
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS
Dosage Strength : 0.4MG/ML
Packaging :
Approval Date : 2023-09-28
Application Number : 21272
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TYVASO
Dosage Form : SOLUTION;INHALATION
Dosage Strength : 0.6MG/ML
Packaging :
Approval Date : 2009-07-30
Application Number : 22387
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 20MG/20ML (1MG/ML)
Packaging :
Approval Date : 2018-07-30
Application Number : 208276
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 50MG/20ML (2.5MG/ML)
Packaging :
Approval Date : 2018-07-30
Application Number : 208276
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/20ML (5MG/ML)
Packaging :
Approval Date : 2018-07-30
Application Number : 208276
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : REMODULIN
Dosage Form : SOLUTION;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 200MG/20ML (10MG/ML)
Packaging :
Approval Date : 2018-07-30
Application Number : 208276
Regulatory Info : DISCN
Registration Country : USA
LOOKING FOR A SUPPLIER?
